Publications

Breast (Edinburgh, Scotland)

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

01-02-2026

Breast (Edinburgh, Scotland)

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

01-02-2026

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

03-11-2025

International journal of cancer

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

01-08-2025

BMJ open

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

09-10-2024

Genetics in medicine : official journal of the American College of Medical Genetics

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

01-09-2024

medRxiv : the preprint server for health sciences

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

13-02-2024

Scandinavian journal of medicine & science in sports

Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.

01-02-2024

BMC medicine

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

09-01-2024

Journal of empirical research on human research ethics : JERHRE

Health Research with Data in a Time of Privacy: Which Information do Patients Want?

01-10-2023

Cancer medicine

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

01-08-2023

Nature communications

Obesity-associated changes in molecular biology of primary breast cancer.

21-07-2023

Breast cancer research : BCR

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.

20-06-2023

Breast cancer research : BCR

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.

09-05-2023

Journal of the National Cancer Institute

Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.

08-12-2022

Journal of medical genetics

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.

01-12-2022

Breast cancer research : BCR

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

21-10-2022

European journal of cancer (Oxford, England : 1990)

Incorporating progesterone receptor expression into the PREDICT breast prognostic model.

01-09-2022

Genome medicine

Breast cancer risks associated with missense variants in breast cancer susceptibility genes.

18-05-2022

Communications biology

Rare germline copy number variants (CNVs) and breast cancer risk.

18-01-2022

Breast cancer research : BCR

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

04-01-2022

Journal of hematology & oncology

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

17-04-2021

Journal of the National Cancer Institute

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

01-03-2021

American journal of human genetics

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

05-11-2020

NPJ breast cancer

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

03-11-2020

Nature genetics

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

01-06-2020

Nature communications

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

16-01-2020

Nature genetics

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

01-01-2020

EBioMedicine

Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry.

01-10-2019

Annals of surgery

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.

01-08-2019

British journal of sports medicine

Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data.

01-07-2019

International journal of epidemiology

Authors' response: Associations of obesity and circulating insulin and glucose with breast cancer risk.

01-06-2019

Blood

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

07-03-2019

Diabetes care

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries.

01-03-2019

American journal of human genetics

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

03-01-2019

Oncoimmunology

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival.

14-12-2018

Nature genetics

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

01-07-2018

International journal of epidemiology

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

01-04-2018

BMC cancer

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.

27-02-2018

Oncotarget

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

28-11-2017

European journal of cancer (Oxford, England : 1990)

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

01-06-2017

Nature genetics

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

01-06-2017

Breast cancer research : BCR

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

22-05-2017

Breast cancer research : BCR

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

03-10-2016

PLoS medicine

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

01-08-2016

Nature communications

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

27-04-2016

PloS one

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

31-03-2016

Human genetics

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

01-01-2016

BMC medicine

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

02-07-2015

Human molecular genetics

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

15-05-2015

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Health Research with Data in a Time of Privacy: Which Information do Patients Want?

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Obesity-associated changes in molecular biology of primary breast cancer.

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.

Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Incorporating progesterone receptor expression into the PREDICT breast prognostic model.

Breast cancer risks associated with missense variants in breast cancer susceptibility genes.

Rare germline copy number variants (CNVs) and breast cancer risk.

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry.

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.

Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data.

Authors' response: Associations of obesity and circulating insulin and glucose with breast cancer risk.

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival.

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

This site uses cookies